100 Global View Drive
Warrendale, PA 15086
Feature | Antiplatelet and Anticoagulation Therapies | September 12, 2017
September 12, 2017 — Rivaroxaban plus aspirin improves survival and reduces stroke and heart attack in patients with
News | Contrast Media | August 29, 2017
August 29, 2017 — The European Medicines Agency (EMA) issued a final opinion that recommended restricting the use of
News | Hypertension | July 05, 2017
Bayer has enrolled the first patient in a global Phase IV study assessing the clinical effects of riociguat in patients...
Feature | Contrast Media | June 19, 2017 | Dave Fornell
Here are several updates in medical imaging...
News | Radiation Dose Management | March 30, 2017
Connecticut Hospital Association and Bayer to Form First Statewide Radiation Dose Management Repository
The Connecticut Hospital Association (CHA) and Bayer announced an alliance to establish the United States' first-ever...
News | Nuclear Imaging | January 12, 2017
January 12, 2017 — Bayer Healthcare has initiated a recall of all its Medrad Intego PET Infusion System Source Admini
Feature | Radiation Dose Management | May 12, 2016 | Lori Webb, R.T. (R) and Tom Watson, RCVT
Healthcare organizations, clinicians and medical equipment manufacturers have long focused on the management and redu
Technology | Contrast Media | April 29, 2016
Bayer announced that the U.S. Food and Drug Administration (FDA) has approved Gadavist (gadobutrol) injection for use...
News | Contrast Media | April 13, 2016
The global market for contrast media is set to rise from just over $4.3 billion in 2015 to over $6 billion by 2022,...
News | Antiplatelet and Anticoagulation Therapies | September 04, 2015
Janssen Pharmaceuticals Inc. and its development partner Bayer HealthCare announced results from PMSS and XANTUS, real-...